Amyloid light chain (AL) amyloidosis is a rare, debilitating, often fatal disease. Symptoms of
cardiomyopathy are common presenting features, and patients often are referred to …

Despite significant progress and improving outcomes in the management of plasma cell
disorders, AL amyloidosis remains diagnostically and therapeutically challenging for …

The immunoglobulin light-chain amyloidosis is a multisystemic disease which manifests by
damage to the vital organs by light chain-derived amyloid fibril. Traditionally, the treatment …

BACKGROUND: Primary systemic light-chain (AL) amyloidosis is a rare clonal plasma cell
disorder characterized by the production of abnormal immunoglobulin fragments, which form …

Background The prognosis of patients with light‐chain amyloidosis (AL) has improved
markedly in the past decade in China; whether the current staging systems are suitable to …